Est. 2026 · Pennsylvania
The Spain
Divergence
52.6 Donors Per Million · 37 Consecutive Years Leading the World · The Architecture That Produces It
Spain has led the world in deceased organ donation rates for 37 consecutive years. In 2024 it set a new global record: 52.6 donors per million population. The US managed 48.1 — apparently close, but with a discard rate three to four times Spain's, making effective utilization substantially lower. Spain did not achieve this through altruism or luck. It built a different architecture. The difference is structural, not cultural.
The standard explanation for Spain's donation rates begins with presumed consent — Spain's opt-out system, in place since 1979, which designates every citizen a potential donor unless they register an objection. This explanation is incomplete to the point of being misleading.
Spain's opt-out law predates Spain's exceptional donation rates by a decade. Donation rates in Spain were not remarkable in the 1980s. They began their sustained climb after 1989 — not because the law changed, but because the infrastructure changed. The Organización Nacional de Trasplantes, created in 1989, built a new coordination architecture that transformed Spain's performance. The law was the same. The system was different. The results diverged.
This matters because the policy debate in the US and UK frequently focuses on presumed consent legislation as the mechanism for improving donation rates. The Spanish evidence does not support that focus. Countries that have adopted presumed consent without the accompanying organizational infrastructure have seen modest or negligible improvements. The law is a necessary condition for the soft presumed consent environment Spain operates in. It is not sufficient. The architecture is what's sufficient.
Policy implication: Adopt presumed consent and donation rates will improve.
Policy implication: Build the coordinator infrastructure, invest in hospital relationships, professionalize family communication. The law is secondary.
The Organización Nacional de Trasplantes — the ONT — is a national technical agency under Spain's Ministry of Health, created in 1989. It operates on three tiers: the national ONT provides strategy, coordination, logistics support, and quality oversight; regional coordinators manage inter-hospital coordination within Spain's autonomous communities; and hospital transplant coordinators — the model's most important innovation — are embedded within individual hospitals as full members of the clinical staff.
The hospital coordinator is not an external representative of a procurement organization arriving in the ICU after a death. They are a physician or nurse who works in the hospital every day, who has relationships with the ICU team, who is present in the daily clinical environment, and who approaches potential donor families as a member of the care team that has been involved in that patient's treatment — not as an outsider arriving for a transactional purpose.
This structural position changes everything about the family approach. The conversation about donation happens in the context of an established relationship with the care team. The coordinator has been trained specifically in empathetic communication and grief support — not as an add-on to a clinical role, but as the primary skill the role requires. Spain's family refusal rate runs at approximately 15 to 20 percent. The US national average is substantially higher.
Spain did not ask families to donate more generously. It built a system in which the person asking is the person who cared for their family member — present throughout, known, trusted. The architecture of the relationship produces the rate. The rate is not evidence of Spanish generosity. It is evidence of Spanish organizational design.
The single most structurally significant difference between the Spanish and American models is where the procurement coordinator sits — institutionally, physically, and relationally. In Spain, the coordinator is inside the hospital. In the US, the OPO coordinator is outside it. This positional difference is the architectural key to the performance divergence.
Mapped against the FSA framework, the Spanish and American systems are not different versions of the same architecture. They are different architectures that happen to address the same problem. The source layer — deceased donors and their families — is the same. Every other layer diverges.
Lower Refusal Rate
Higher Refusal Rate
Structural Advantage
Structural Disadvantage
Lower Discard Rate
High Discard Rate
Public Accountability
Structural Conflicts
Accountability Maintained
Heavy Insulation
The Spanish Model is not unknown to American transplant medicine. The IOM, the GAO, and academic researchers have examined it for decades. Spanish coordinators and ONT leadership have presented at American conferences. The TPM training program, run by the DTI Foundation linked to the University of Barcelona, has trained coordinators from over 100 countries. American OPO staff have attended those programs.
What the US has not done is adopt the core structural innovation: embedding coordinators inside hospitals as full members of the clinical staff, with hospital funding, clinical standing, and no financial incentive tied to procurement volume. The elements the US has selectively adopted — better family communication training, proactive referral protocols, some performance metrics — are the surface features of the Spanish Model without its structural foundation.
The reason is not ignorance. It is architecture. Embedding coordinators inside hospitals would require hospitals to fund them, which hospitals resist. It would require OPOs to surrender the family approach role, which OPOs resist. It would require the territorial monopoly structure to be disrupted, because in-hospital coordinators would not align neatly with regional OPO boundaries. Every element of the Spanish Model's structural innovation conflicts with the existing US institutional arrangement. The US has studied Spain for decades and learned without implementing because implementation would require dismantling the architecture that this series has documented.
The Spain divergence is the series' most direct evidence that the American organ transplant architecture is not the only possible architecture — it is a choice. The outcomes Spain achieves are achievable. The organizational model that produces them is documented, exportable (the TPM program has trained coordinators in 100+ countries), and well understood by American transplant medicine. The gap between knowing what Spain does and doing it is not a knowledge gap. It is an architecture gap — the existing US institutional arrangement conflicts at every structural layer with the model that produces better outcomes. The discard rate, the OPO performance variation, the governance conflicts, the contractor monopoly — each of these problems has a Spanish analog that was solved by building the architecture differently. The US has studied the solution for decades. The study has not produced the implementation, because implementation would require dismantling what already exists. That is the most important finding of the series.
Final Post · Post VIII · The Modernization — 2023 Securing the US OPTN Act. Multi-vendor rebid. What the reform has produced and what it has not. Whether competition replaced capture or redistributed it.


